+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biosimilar"

Biosimilars Global Market Report 2023 - Product Thumbnail Image

Biosimilars Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
Biosimilars: Global Strategic Business Report - Product Thumbnail Image

Biosimilars: Global Strategic Business Report

  • Report
  • October 2023
  • 193 Pages
  • Global
From
From
Global Biosimilars Market 2023-2027 - Product Thumbnail Image

Global Biosimilars Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
Global Biosimilars Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Biosimilars Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
From
From
From
From
From
Remicade Biosimilar Global Market Report 2023 - Product Thumbnail Image

Remicade Biosimilar Global Market Report 2023

  • Report
  • September 2023
  • 175 Pages
  • Global
From
Insulin biosimilars Global Market Report 2023 - Product Thumbnail Image

Insulin biosimilars Global Market Report 2023

  • Report
  • August 2023
  • 175 Pages
  • Global
From
Bevacizumab Biosimilars Global Market Report 2023 - Product Thumbnail Image

Bevacizumab Biosimilars Global Market Report 2023

  • Report
  • August 2023
  • 175 Pages
  • Global
From
Biologic & Biosimilar RA Drugs Global Market Report 2023 - Product Thumbnail Image

Biologic & Biosimilar RA Drugs Global Market Report 2023

  • Report
  • May 2023
  • 250 Pages
  • Global
From
From
Loading Indicator

The Biosimilar market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs that are similar to existing biologic drugs. Biosimilars are created using a process called recombinant DNA technology, which involves the manipulation of genetic material to create a drug that is similar to an existing biologic drug. Biosimilars are typically used to treat chronic conditions such as cancer, rheumatoid arthritis, and multiple sclerosis. Biosimilars are typically cheaper than their brand-name counterparts, making them an attractive option for patients and healthcare providers. Some companies in the Biosimilar market include Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Mylan, Pfizer, Sandoz, and Teva Pharmaceuticals. Show Less Read more